Sources | Names Used |
---|---|
CTRPv2 | SR-II-138A |
PharmacoGx | SR-II-138A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SNCB | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
mRNA | USP42 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
mRNA | ABRACL | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | CA6 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.003 |
mRNA | ACVR2B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | LRRC29 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
mRNA | SPATA31D3 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.003 |
mRNA | USP3 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
mRNA | CTD-2616J11.11 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |
mRNA | GABRA1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.003 |